# Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children

> **NCT06929702** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University Hospital, Ghent** · enrollment: 58 (estimated)

## Conditions studied

- Amoxicillin-clavulanate
- Piperacillin-tazobactam
- Meropenem

## Interventions

- **DRUG:** Beta-lactam antibiotic
- **DEVICE:** Beta-lactam model-informed precision dosing

## Key facts

- **NCT ID:** NCT06929702
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-22
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2025-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06929702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06929702, "Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06929702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*